First Header Logo Second Header Logo

Connection

Donald Mcclain to Lymphoma, Non-Hodgkin

Back to Details
This is a "connection" page, showing publications Donald Mcclain has written about Lymphoma, Non-Hodgkin.
Donald Mcclain
Connection Strength
0.151
Lymphoma, Non-Hodgkin
  1. Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Leuk Lymphoma. 2018 08; 59(8):1871-1877.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.